TABLE 2.
Total |
Conventional therapy |
P | ||
---|---|---|---|---|
Failure | Intolerance | |||
Age, years | 50 (25–80) | 46.3 (25–61) | 55.7 (35–80) | 0.12 |
Female, % | 81 | 75 | 89 | 0.73 |
Weight, kg | 79 (47–117) | 82 (47–117) | 75 (61–91) | 0.92 |
Alkaline phosphatase, U/L (normal <140 U/L) | 232 (82–1522) | 156 (91–260) | 346 (82–1522) | 0.30 |
Aspartate aminotransferase, U/L (normal <35 U/L) | 801 (64–3967) | 880 (64–3967) | 695 (95–3099) | 0.41 |
Alanine aminotransferase (normal <40 U/L) | 762 (72–3218) | 746 (72–3218) | 782 (94–1659) | 0.79 |
Immunoglobulin G, g/L (normal range 7 g/L–16 g/L) | 22.1 | 18.8 | 26.7 | 0.34 |
White blood cell count, ×109/L | 7.7 (2.2–11.2) | 7.6 (3.6–11.2) | 7.8 (2.2–10.9) | 0.90 |
Data presented as mean (range) unless indicated otherwise